DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share guidance of $2.00-$2.10 for the period, compared to the consensus earnings per share estimate of $2.06. The company issued revenue guidance of $3.91-$3.97 billion, compared to the consensus revenue estimate of $4.00 billion.
Wall Street Analyst Weigh In
XRAY has been the topic of several analyst reports. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating on the stock in a research report on Friday. Leerink Partnrs restated an outperform rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. SVB Leerink started coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an outperform rating and a $42.00 price target for the company. Evercore ISI decreased their price target on DENTSPLY SIRONA from $40.00 to $35.00 and set an outperform rating on the stock in a report on Friday. Finally, Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research note on Friday. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and a consensus price target of $36.90.
Read Our Latest Analysis on XRAY
DENTSPLY SIRONA Stock Performance
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.39 earnings per share. On average, equities research analysts anticipate that DENTSPLY SIRONA will post 2.04 EPS for the current fiscal year.
DENTSPLY SIRONA Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- Investing in large cap stocks: Diving into big caps
- MarketBeat Week in Review – 4/29 – 5/3
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.